0 Comments
0 Shares
45 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
- Please log in to like, share and comment!
- Critical Limb Ischemia Treatment Market Growth Driven by Aging Population and Diabetes“Critical Limb Ischemia (CLI) Treatment Market reached US$ 6.02 billion in 2024 and is expected to reach US$ 13.13 billion by 2032, growing at a CAGR of 7.9 % during the forecast period 2025-2032”, according to DataM Intelligence report. Download Free Sample Report: https://www.datamintelligence.com/download-sample/critical-limb-ischemia-treatment-market?sindhuri Critical Limb...0 Comments 0 Shares 23 Views 0 Reviews
- Diabetes Drugs Market Growth Accelerates with Biologics, Biosimilars & AIThe Global Diabetes Drugs Market reached US$ 78.11 billion in 2024 and is expected to reach US$ 141.73 billion by 2032, growing at a CAGR of 7.8 % during the forecast period 2025-2032, according to DataM Intelligence report. Unlock exclusive insights with our detailed sample report :...
- Glucagon-like Peptide 1 Market Set for Massive Growth by 2033“Glucagon-like Peptide 1 (GLP-1) Analogues Market reached US$ 62.81 Billion in 2024 and is expected to reach US$ 299.08 Billion by 2033, growing at a CAGR of 17.6 % during the forecast period 2025-2033”,according to DataM Intelligence report. Download Sample Report: https://www.datamintelligence.com/download-sample/glucagon-like-peptide-1-analogues-market?sindhuri The Glucagon-like...0 Comments 0 Shares 44 Views 0 Reviews
- Hospitals Dominate Distribution ChannelsThe global diabetic neuropathy market—focused on managing nerve damage caused by diabetes—is expected to grow from approximately USD 4.34 billion in 2023 to USD 7.28 billion by 2030, registering a CAGR of 7.7%. As the number of diabetes cases escalates worldwide, so does the need for effective neuropathy diagnostics and treatments. Market Snapshot 2023 Market Size: USD 4.34...0 Comments 0 Shares 154 Views 0 Reviews
More Results